Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
about
Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring.Future perspectives in cancer immunotherapyCetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancerImpact of MLH1 expression on tumor evolution after curative surgical tumor resection in a murine orthotopic xenograft model for human MSI colon cancer.Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials.Implementing liquid biopsies into clinical decision making for cancer immunotherapy.The immune contexture in cancer prognosis and treatment.Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases.Introduction: Cancer Immunology Special Issue-Immunopathology.CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.Classifying the evolutionary and ecological features of neoplasms.Predictive value of different proportion of lesion HLA-G expression in colorectal cancer.Lymphangiogenesis guidance by paracrine and pericellular factors.Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma.Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer.Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.Efficacy of Early Enteral Immunonutrition on Immune Function and Clinical Outcome for Postoperative Patients With Gastrointestinal Cancer.Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma.A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
P2860
Q33876878-1C6E70CC-7EE6-47FB-8617-4D7F4A8690A8Q37147632-C79A5897-5875-4A57-973B-8171D5440C6EQ37735615-89FAF434-4DAA-4C3B-BE91-33D458D69B7FQ38703244-8EBBE678-75DF-4792-8715-DDDE723BBB6FQ38774106-CAC4FA4B-13B4-4FC1-84D9-ABC4CCBA3563Q39304648-4647AD51-A177-47BB-A89E-601D6363F780Q39456999-9FE0DCB3-C101-4FAA-B721-F62026A5F520Q40475503-2AB0D7E0-96B0-4938-93E0-87DCAD2FD3FFQ41708934-29457DE3-4505-4F60-88D7-AA398BFDEEF9Q42288391-C07E290C-07AC-467A-95B2-53990D1D1C8BQ42354401-65B96E87-8C15-4C46-920C-CB77A9525387Q42683596-7139C948-B15B-4A78-A625-153D95D2F5DFQ45067426-B1D97767-7462-4501-8656-CB735E84F51DQ47139094-E9EC412A-6C36-4E1D-9903-237EC158308AQ47744569-EB1A3065-D4FF-4C93-951E-0805C69CA7B6Q48353128-913A5499-B6E9-4964-87C5-0352B6D5C9EBQ49461513-B9C92F6F-CE0D-481A-8D70-99076575A729Q52655048-763A6BB2-5CFA-4DEF-ADEC-BC35143C0855Q52764085-BC27E571-27D4-4BE4-B50A-DA8034C90F45Q55513615-27703EB3-A9A8-4847-A6C6-2834FED39AAAQ58693496-BD07071D-A969-47C5-A6C6-914B6E377976
P2860
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rational bases for the use of ...... biomarker in cancer patients.
@en
type
label
Rational bases for the use of ...... biomarker in cancer patients.
@en
prefLabel
Rational bases for the use of ...... biomarker in cancer patients.
@en
P2093
P2860
P356
P1476
Rational bases for the use of ...... biomarker in cancer patients.
@en
P2093
Amos Kirilovsky
Carine El Sissy
Florence Marliot
Franck Pagès
Nacilla Haicheur
P2860
P304
P356
10.1093/INTIMM/DXW021
P577
2016-04-27T00:00:00Z